• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于体内研究脑 5 - 羟色胺(5 - HT)1A 受体的放射性配体——某些 WAY 新类似物的研发

Radioligands for the study of brain 5-HT(1A) receptors in vivo--development of some new analogues of way.

作者信息

Pike V W, Halldin C, Wikström H, Marchais S, McCarron J A, Sandell J, Nowicki B, Swahn C G, Osman S, Hume S P, Constantinou M, Andrée B, Farde L

机构信息

MRC Cyclotron Unit, Imperial College School of Medicine, Hammersmith Hospital, Ducane Road, London W12 ONN, United Kingdom.

出版信息

Nucl Med Biol. 2000 Jul;27(5):449-55. doi: 10.1016/s0969-8051(00)00110-4.

DOI:10.1016/s0969-8051(00)00110-4
PMID:10962249
Abstract

[Carbonyl-(11)C]WAY-100635 (WAY) has proved to be a very useful radioligand for the imaging of brain 5-HT(1A) receptors in human brain in vivo with positron emission tomography (PET). WAY is now being applied widely for clinical research and drug development. However, WAY is rapidly cleared from plasma and is also rapidly metabolised. A comparable radioligand, with a higher and more sustained delivery to brain, is desirable since these properties might lead to better biomathematical modelling of acquired PET data. There are also needs for other types of 5-HT(1A) receptor radioligands, for example, ligands sensitive to elevated serotonin levels, ligands labelled with longer-lived fluorine-18 for distribution to "satellite" PET centres, and ligands labelled with iodine-123 for single photon emission computerised tomography (SPECT) imaging. Here we describe our progress toward these aims through the exploration of WAY analogues, including the development of [carbonyl-(11)C]desmethyl-WAY (DWAY) as a promising, more brain-penetrant radioligand for PET imaging of human 5-HT(1A) receptors, and (pyridinyl-6-halo)-analogues as promising leads for the development of radiohalogenated ligands.

摘要

[羰基-(11)C]WAY-100635(WAY)已被证明是一种非常有用的放射性配体,可通过正电子发射断层扫描(PET)在人体内对脑5-HT(1A)受体进行活体成像。WAY目前正广泛应用于临床研究和药物开发。然而,WAY会迅速从血浆中清除,并且代谢也很快。由于这些特性可能会导致对获取的PET数据进行更好的生物数学建模,因此需要一种具有更高且更持续的脑内递送的类似放射性配体。还需要其他类型的5-HT(1A)受体放射性配体,例如,对血清素水平升高敏感的配体、用半衰期更长的氟-18标记以便分发给“卫星”PET中心的配体,以及用碘-123标记用于单光子发射计算机断层扫描(SPECT)成像的配体。在此,我们通过探索WAY类似物来描述我们在实现这些目标方面的进展,包括开发[羰基-(11)C]去甲基-WAY(DWAY)作为一种有前景的、脑渗透性更强的用于人类5-HT(1A)受体PET成像的放射性配体,以及(吡啶基-6-卤代)类似物作为放射性卤化配体开发的有前景的先导化合物。

相似文献

1
Radioligands for the study of brain 5-HT(1A) receptors in vivo--development of some new analogues of way.用于体内研究脑 5 - 羟色胺(5 - HT)1A 受体的放射性配体——某些 WAY 新类似物的研发
Nucl Med Biol. 2000 Jul;27(5):449-55. doi: 10.1016/s0969-8051(00)00110-4.
2
A retrospect on the discovery of WAY-100635 and the prospect for improved 5-HT(1A) receptor PET radioligands.WAY-100635的发现回顾与改进的5-HT(1A)受体PET放射性配体的前景
Nucl Med Biol. 2000 Jul;27(5):441-7. doi: 10.1016/s0969-8051(00)00109-8.
3
The PET radioligand [carbonyl-(11)C]desmethyl-WAY-100635 binds to 5-HT(1A) receptors and provides a higher radioactive signal than [carbonyl-(11)C]WAY-100635 in the human brain.PET放射性配体[羰基-(11)C]去甲基-WAY-100635与5-HT(1A)受体结合,且在人脑内比[羰基-(11)C]WAY-100635产生更高的放射性信号。
J Nucl Med. 2002 Mar;43(3):292-303.
4
Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug development.正电子发射断层扫描(PET)及放射性配体[羰基 - (11)C]WAY - 100635在精神药物研发中的应用。
Nucl Med Biol. 2000 Jul;27(5):515-21. doi: 10.1016/s0969-8051(00)00121-9.
5
New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey.新型卤代[11C]WAY类似物,[11C]6FPWAY和[11C]6BPWAY——作为活体猴脑5-HT1A受体研究放射性配体的放射性合成与评估
Nucl Med Biol. 2001 Feb;28(2):177-85. doi: 10.1016/s0969-8051(00)00181-5.
6
Imaging the 5-HT(1A) receptors with PET: WAY-100635 and analogues.用正电子发射断层扫描(PET)成像5-羟色胺(1A)受体:WAY-100635及其类似物。
Nucl Med Biol. 2000 Jul;27(5):463-6. doi: 10.1016/s0969-8051(00)00112-8.
7
[carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.[羰基-11C]去甲基-WAY-100635(DWAY)在体外和体内都是一种针对中枢5-羟色胺1A受体的强效且选择性放射性配体。
Eur J Nucl Med. 1998 Apr;25(4):338-46. doi: 10.1007/s002590050230.
8
[(18)F]p-MPPF: aA radiolabeled antagonist for the study of 5-HT(1A) receptors with PET.[18F]对甲基哌嗪氟苯:一种用于正电子发射断层扫描(PET)研究5-羟色胺(5-HT)1A受体的放射性标记拮抗剂。
Nucl Med Biol. 2000 Jul;27(5):467-71. doi: 10.1016/s0969-8051(00)00113-x.
9
Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.5-羟色胺1A受体放射性配体[羰基-¹¹C]WAY-100635在猴和人血浆中放射性代谢物外观的表征——正电子发射断层扫描中高信号对比度的解释及对生物数学建模的辅助
Nucl Med Biol. 1998 Apr;25(3):215-23. doi: 10.1016/s0969-8051(97)00206-0.
10
Drug action at the 5-HT(1A) receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-(11)C]WAY-100635.体内5-羟色胺(1A)受体的药物作用:用正电子发射断层扫描(PET)和[羰基-(11)C] WAY-100635检测自身受体和突触后受体占有率。
Nucl Med Biol. 2000 Jul;27(5):509-13. doi: 10.1016/s0969-8051(00)00120-7.

引用本文的文献

1
An in vivo comparison of cis- and trans-[18F]mefway in the nonhuman primate.在非人灵长类动物中顺式和反式[18F]mefway 的体内比较。
Nucl Med Biol. 2011 Oct;38(7):925-32. doi: 10.1016/j.nucmedbio.2011.04.001. Epub 2011 Jul 7.
2
In vivo kinetics of [F-18]MEFWAY: a comparison with [C-11]WAY100635 and [F-18]MPPF in the nonhuman primate.体内[F-18]MEFWAY 的动力学:与非人类灵长类动物中[C-11]WAY100635 和[F-18]MPPF 的比较。
Synapse. 2011 Jul;65(7):592-600. doi: 10.1002/syn.20878. Epub 2010 Dec 8.
3
Synthesis and biological evaluation of new [Tc(N)(PS)]-based mixed-ligand compounds useful in the design of target-specific radiopharmaceuticals: the 2-methoxyphenylpiperazine dithiocarbamate derivatives as an example.
新型基于[Tc(N)(PS)]的混合配体化合物的合成与生物评价:以 2-甲氧基苯基哌嗪二硫代氨基甲酸酯衍生物为例,用于设计靶向放射性药物。
J Biol Inorg Chem. 2011 Jan;16(1):137-55. doi: 10.1007/s00775-010-0712-4. Epub 2010 Oct 7.